Structure-guided engineering of immunotherapies targeting TRBC1 and TRBC2 in T cell malignancies. (2024)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41467-024-45854-3

PubMed Identifier: 38383515

Publication URI: http://europepmc.org/abstract/MED/38383515

Type: Journal Article/Review

Volume: 15

Parent Publication: Nature communications

Issue: 1

ISSN: 2041-1723